NREP
NEW REPRESENTATIVE AT IB RECEIVED
06/11/2026
Back to search
Official data from USPTO
MATRIXOME
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
17
Latest update
06/12/2026
Trademark type
Word
Nice classes
1, 5
Filing date
02/25/2022
Registration date
04/11/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/11/2023
Last transaction
06/12/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
03
Owner location
JP
Examiner
SCHLEGELMILCH, JONATHON A
Law office
L80
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
MATRIXOME, Inc.
Representatives
KIMURA Mitsuru
Technical classification
Nice Classes
Class 1Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Proteins for use in the manufacture of pharmaceuticals and biological preparations other than for medical or veterinary use; proteins in raw material form for scientific and medical research use to enhance cell proliferation and viabilityother than for medical or veterinary use; proteins in raw material form for scientific and medical research use as substrates in cell culturesother than for medical or veterinary use; biological reagents for scientific and medical research use in cell cultures other than for medical or veterinary use; chemical preparations for scientific and medical research use in cell cultures other than for medical or veterinary use; chemical reagents for use in cell cultures other than for medical or veterinary use; proteins in raw material form for scientific and medical researchother than for medical or veterinary use; chemical preparations for scientific and medical research use other than for medical or veterinary use; chemical reagents other than for medical or veterinary use
Class 5
Cell culture substratesprotein specifically adapted for use with nucleic acid sequences for use in cell cultures for medicalclinicalveterinary diagnostic use; reagents for use in cell cultures for medicalclinical medicalveterinary diagnostic use; recombinant protein being biochemical preparations specially adapted for use with nucleic acid sequences for medical purposes; chemical reagents for medical and veterinary use; chemical preparations for medical purposesreagents for medical use
Publications
History of USPTO decisions and trademark events.
17 publications found
GPNX
NOTIFICATION PROCESSED BY IB
06/05/2023
FICS
FINAL DISPOSITION NOTICE SENT TO IB
05/16/2023
FIMP
FINAL DISPOSITION PROCESSED
05/16/2023
GPAR
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
05/11/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
04/11/2023
GPNX
NOTIFICATION PROCESSED BY IB
01/25/2023
PUBO
PUBLISHED FOR OPPOSITION
01/24/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
01/04/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
01/04/2023
NPUB
NOTICE OF PUBLICATION
01/04/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/20/2022
DOCK
ASSIGNED TO EXAMINER
12/09/2022
MAFR
APPLICATION FILING RECEIPT MAILED
09/30/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/26/2022
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
09/22/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
09/16/2022
Continuous trademark protection
Get notified about every new filing that threatens MATRIXOME or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.